51
TITLE: The regulatory landscape: implications for design and development of nanomedicines
AUTHORS: Gaspar, R;
PUBLISHED: 2009, SOURCE: JOURNAL OF PHARMACY AND PHARMACOLOGY, VOLUME: 61
INDEXED IN: WOS
52
TITLE: Polymeric carriers
AUTHORS: Rogerio Gaspar; Ruth Duncan;
PUBLISHED: 2009, SOURCE: ADVANCED DRUG DELIVERY REVIEWS, VOLUME: Vol. 61
INDEXED IN: Handle
54
TITLE: Regulatory issues surrounding nanomedicines
AUTHORS: Rogerio Gaspar;
PUBLISHED: 2007, SOURCE: NANOMEDICINE, VOLUME: Vol. 2
INDEXED IN: Handle
55
TITLE: Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCl-H82 variant small cell lung cancer  Full Text
AUTHORS: Moreira, JN ; Gaspar, R;
PUBLISHED: 2004, SOURCE: BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, VOLUME: 37, ISSUE: 8
INDEXED IN: Scopus WOS
IN MY: ORCID
57
TITLE: The effect of haemoglobin pretreatment on the liver ischaemia/reperfusion injury  Full Text
AUTHORS: Sepodes, B; Pinto, R; McDonald, M; Thiemermann, C; Mota Filipe, H;
PUBLISHED: 2004, SOURCE: FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOLUME: 18
INDEXED IN: WOS
58
TITLE: Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
AUTHORS: Fonseca, C; Simoes, S ; Gaspar, R;
PUBLISHED: 2002, SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 83, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef Handle
IN MY: ORCID
59
TITLE: Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity  Full Text
AUTHORS: Moreira, JN ; Ishida, T; Gaspar, R; Allen, TM;
PUBLISHED: 2002, SOURCE: PHARMACEUTICAL RESEARCH, VOLUME: 19, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 92
IN MY: ORCID
60
TITLE: Targeting Stealth liposomes in a murine model of human small cell lung cancer
AUTHORS: Moreira, JN ; Gaspar, R; Allen, TM;
PUBLISHED: 2001, SOURCE: BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, VOLUME: 1515, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef Handle
IN MY: ORCID
Page 6 of 9. Total results: 82.